Meda AB Extraordinary General Meeting Bulletin

Regulatory News:

At the extraordinary general meeting (EGM) on November 6, 2014 of Meda AB (publ)(STO:MEDA-A)(Pink Sheets:MDABY), it was resolved to approve the board of director’s resolution as of October 10, 2014, to launch a rights issue of shares of series A shares with preferential rights for Meda’s shareholders. The purpose of the rights issue is to finance part of the acquisition of Rottapharm.

Help employers find you! Check out all the jobs and post your resume.

Back to news